Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Severe Mental Disorders”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT06580860
What this trial is testing

Psychiatric Multi-omics and Neuroimaging Project

Who this might be right for
Mental DisordersHealthy Control
mingjun Zhong 1,899
Testing effectiveness (Phase 2)Study completedNCT01525524
What this trial is testing

Treatment of Major Depressive Disorder Post Stroke With Transcranial Direct Current Stimulation

Who this might be right for
Major Depressive Disorder 1
University of Sao Paulo 48
Large-scale testing (Phase 3)Looking for participantsNCT07484217
What this trial is testing

Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using Solriamfetol

Who this might be right for
Major Depressive Disorder With Excessive Daytime Sleepiness Symptoms
Axsome Therapeutics, Inc. 508
Not applicableStudy completedNCT05431374
What this trial is testing

Measurement-Based Care Vs. Standard Care for Major Depressive Disorder

Who this might be right for
Major Depressive Disorder
Pakistan Institute of Living and Learning 150
Not applicableStudy completedNCT02143024
What this trial is testing

A Family-based Primary Care Intervention to Enhance Older Men's Depression Care

Who this might be right for
Major Depression
University of California, Davis 23
Early research (Phase 1)Ended earlyNCT02942368
What this trial is testing

Adaptive tDCS for Treatment-Resistant MDD

Who this might be right for
Depressive Disorder, Treatment-Resistant
Washington University School of Medicine 5
Testing effectiveness (Phase 2)Looking for participantsNCT07562191
What this trial is testing

Inhaled DMT for Major Depressive Disorder

Who this might be right for
MDDMajor Depressive Disorder (MDD)Major Depression+2 more
Universidade Federal do Rio Grande do Norte 140
Not applicableStudy completedNCT02860910
What this trial is testing

Cognitive Behavioral Group Therapy for the Management of Menopause Symptoms in Mood Disorders

Who this might be right for
Bipolar DisorderMajor Depressive DisorderMenopause
Danette Conklin, PhD 59
Not applicableStudy completedNCT03449979
What this trial is testing

Single Session of tACS in a Depressive Episode

Who this might be right for
DepressionMajor Depressive DisorderPremenstrual Dysphoric Disorder+1 more
University of North Carolina, Chapel Hill 84
Not applicableLooking for participantsNCT07105397
What this trial is testing

Evaluating Conversational Artificial Intelligence for Depression Management

Who this might be right for
Major Depressive Disorder (MDD)
George Mason University 130
Not applicableLooking for participantsNCT07127913
What this trial is testing

Closed-Loop Deep Brain Stimulation for Treatment-Resistant Bipolar Depression

Who this might be right for
Bipolar II DisorderBipolar II Disorder, Most Recent Episode Major Depressive
Andrew Krystal 10
Not applicableWithdrawnNCT01613820
What this trial is testing

Ketamine and Scopolamine Infusions for Treatment-resistant Major Depressive Disorder

Who this might be right for
Major Depressive Disorder
Massachusetts General Hospital
Testing effectiveness (Phase 2)Study completedNCT01004393
What this trial is testing

Methylnaltrexone for Opioid-induced Constipation in Cancer Patients

Who this might be right for
NeoplasmsConstipationOpioid-Related Disorders
University of Vermont 12
Not applicableStudy completedNCT00457106
What this trial is testing

A Single-Blind Trial of Risperidone vs. Paroxetine for Treatment of Panic Attacks

Who this might be right for
Major Depression With Panic AttacksPanic Disorder
Beth Israel Medical Center 90
Testing effectiveness (Phase 2)Study completedNCT00048204
What this trial is testing

A New Medicine (GW597599B) For The Treatment Of Major Depressive Disorder

Who this might be right for
Depressive Disorder, Major
GlaxoSmithKline 372
Large-scale testing (Phase 3)Study completedNCT05061706
What this trial is testing

Multicenter Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder

Who this might be right for
Major Depressive Disorder
Intra-Cellular Therapies, Inc. 480
Not applicableStudy completedNCT00205933
What this trial is testing

Behavioral Processes Underlying Reward Processing in Depression

Who this might be right for
Major Depressive DisorderBipolar Disorder
Affective Neuroscience Laboratory 78
Not applicableLooking for participantsNCT06093906
What this trial is testing

Positive Processes and Transition to Health (PATH)

Who this might be right for
Posttraumatic Stress DisorderMajor Depressive Disorder
Case Western Reserve University 135
Large-scale testing (Phase 3)Study completedNCT01942733
What this trial is testing

Study of Brexpiprazole as Adjunctive Treatment of Sleep Disturbances in Patients With Major Depressive Disorder

Who this might be right for
Sleep Disturbances
H. Lundbeck A/S 44
Large-scale testing (Phase 3)Study completedNCT02196506
What this trial is testing

Study of the Safety and Efficacy of Fixed-dose Brexpiprazole (OPC-34712) as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder With and Without Anxious Distress

Who this might be right for
Depressive DisorderDepressionDepressive Disorder, Major+2 more
Otsuka Pharmaceutical Development & Commercialization, Inc. 837
Next Page